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1764-51 Microvascular Integrity Preserves Contractile
Reserve in Post-Infarction Dysfunctioning
Myocardium
Venanzio F. Napoli, Cataldo Memmola, Leonarda Galiuto, Alfredo Marchese,
Paolo Colonna, Vito Marangelli, Sabino Iliceto, Paolo Rizzon. Institute of Cardiology,
Bari UniversJly, Italy
In post myocardial infarction (MI) dysfunctioning segments (Sl. contrast en-
hancement observed during myocardial contrast echo (MCE) is an indicator
of anatomic microvascular integrity. To investigate the functional effect of
preserved microvasculature in maintaining myocardial contractile reserve, 13
pts were studied soon after acute MI (~10 days) by (1) intracoronary MCE
and (2) omniplane transesophageal echo (TEE) LV imaging in baseline condi-
tions (B) and during low dose dobutamine infusion (5 mcglkg/m' for 5' and 10
mcg/kg/m' for 5') (0). MCE was performed by injecting sonicated ioxaglate
in both coronaries. A 13 S model was used for LV analysis both at MCE and
TEE. In 40 dysfunctioning S (a- or severely hypo-kinetic) with excellent MCE
and TEE imaging, myocardial thickening (%Th) was evaluated at B and dur-
ing O. These 40 S were divided in 2 groups according to MCE results: 12 S
without contrast enhancement (Gl I, 28 S with contrast enhancement (G2).
Among the 28 S with contrast enhancement 18 S had contrast enhancement
after contrast injection in the infarcted related artery (IRA), while the remain-
ing 10 after injection in collateral circulation (CC) in the presence of occluded
IRA.
Results:
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Platelet Hyperaggregability in Hypercholesterolemic
Humans: Reversal by Dietary L-Arginine
Christoff Zalpour. Gregor Theilmeier, Adrian Ma. Andreas Wolf. Barbara Anderson,
Philip S. Tsao, John P. Cooke. Stanford University, Stanford. CA
We have shown that vascular NO activity is reduced in hypercholesterolemic
animals, and that this abnormality can be reversed by dietary L-arginine (Arg)
supplementation. A sustained improvement in vascular NO actiVity is associ-
ated with a reduction in platelet reactivity and elevation of platelet cGMP that
is reversed by NO synthase inhibition. This study tested the hypothesis that
chronic Arg supplementation would inhibit platelet reactivity in hypercholes-
terolemic humans. Venous blood was collected from normal (NC; n = 11)
and hypercholesterolemic (HC; n = 22) volunteers for isolation of platelet-
rich plasma and aggregometry. Half the HC group received Arg (8.4 g/d) for
2 weeks; aggregometry was performed using collagen (5 JLg!ml) before and
after 2 wks of treatment, and after a 2-wk washout.
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n = number of S: • = p < 0.001 vs G2: •• = p < 0.0001 vs B. 0 vs B in Gl = ns
John M. Erikson. Paul A. Grayburn, Waleed Irani, Jose Escobar, Carlos E. Velasco.
Veterans Affairs Medical Center and University of Texas Southwestern Medical Center,
Dallas. Texas
Results: HC platelets were hyperaggregable (71 ± 3 v 56 ± 6 aggregation
units [au]; HC v NC; p < 0.03). After 2 wks of Arg, HC platelets were no
different in reactivity (64 ± 7 v 61 ± 6 au). This decrease of aggregability was
sustained for 2 wks after discontinuing Arg (47 ± 9 v 60 ± 5 au; HC v NC).
Figure shows change in au over time in HC-treated v untreated subjects.
Conclusion: These studies are consistent with our previous observations
in animals that Arg inhibits platelet reactivity. The effect of Arg is likely medi-
ated by its conversion to NO.
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1765-21 Dietary L-Arginine Attenuates Macrophage Infiltration
and Intimal Hyperplasia After Balloon Injury
Robert C. Candipan, Bing-yin Wang. Paul TC. Hsiun, Merhdad Arjomandi. Philip
S. Tsao. John P. Cooke. Stanford University, Stanford, CA
Balloon injury in arteries of hypercholesterolemic animals creates a myoin-
timal lesion that is comprised of macrophages as well as vascular smooth
muscle cells. We have shown that chronic administration of L-arginine (Arg)
enhances endothelial NO production and inhibits both monocyte-vessel wall
interaction and plaque formation. Accordingly, we hypothesized that di-
etary Arg would reduce lesion formation and macrophage infiltration in hy-
percholesterolemic animals following balloon injury. NZW rabbits were di-
vided into 3 groups: Normal chow (N). 0.5% cholesterol (Choll, or 0.5%
Chol +2.25% Arg supplementation. Treatment was initiated 6 weeks prior
to balloon injury of the left iliac artery. Four weeks after injury, the lIiacs
were harvested for: assessment of endothelium-dependent relaxation by va-
sodilation to acetylcholine; histology; and immunohistochemistry to assess
macrophage infiltration. Endothelium-dependent relaxation was impaired fol-
lowing injury in the Chol and Arg groups (32 v 4 v 2%, N v Chol v Arg). In
the contralateral non-injured arteries, Arg treatment restored endothelium-
dependent relaxation (79 v 44 v 64%, N v Chol v Arg). The Chol group showed
a 2.5-fold increase in intimal area following injury compared with N, while
Arg attenuated lesion formation (0.28 v 0.69 v 0.34 mm2, N v Chol v Arg, p
< 0.01). Area involved by macrophage increased in the Chol iliacs compared
with N, while Arg significantly attenuated macrophage infiltration (2 v 28 v
5%, N v Arg v Chol, p < 0.001).
Conclusion: Chronic arginine supplementation reduces intimal prolifera-
tion and attenuates macrophage infiltration following balloon injury in hy-
percholesterolemic animals, and is associated with restored NO-dependent
vasodilation.
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Effect of a New Phase Shift Echo Contrast Agent on
Myocardial Blood Flow and Hemodynamics
S(n) B%Th
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Gl 12 • [ 7.7 ± 12.5 12.4 ± 16.6].
G2 28 202 ± 118 28.7 ± 14.8
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We have demonstrated the accuracy of myocardial area at risk and infarct
size determinations with an emulsion of dodecafluoropentane (EchoGen =
EG) which is liquid at room temperature and a gas at body temperature (AHA
meeting). To determine the effect of EG on myocardial blood flow (MBF), 10
fully anesthetized dogs received 4 (30 min apart) or 8 (10 min apart) periph-
eral intravenous injections of EG 0.5 mllkg. HR, BP. T. PAP. PCWP. and CO
were monitored. MBF was assessed with radiolabeled microspheres. Echo
images were recorded with TEE. MBF (ml/min/g, ± SEM) was determined
in four slices of the left ventricle (LV). Serial assessments of LV wall motion
were performed.
Conclusion: in post MI dysfunctioning Swith microvascular integrity, as as-
sessed by MCE, myocardial viability and contractile reserve are preserved.
In fact. dysfunctioning S in the infarct area with contrast enhancement have
greater %Th than S without, not only at B, but also during low dose 0 infu-
sion. Both IRA and CC supply to dysfunctioning myocardium with microvas-
culature integrity are effective in preserving contractile reserve.
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PCWP. CO, and MBF were unchanged following 4 doses of EG. Systemic
hypotension was seen, similar to that observed during administration of
other perfluorochemicals in dogs. Pulmonary hypertension and deterioration
in LV function were seen with 8 doses at 10 min intervals (cumulative dose:
4.0 ml/kg).
Conclusion: Administration of EG at frequent intervals can lead to a sig-
nificant increase in PAP and myocardial dysfunction. However, EG does not
produce significant alteration of MBF or PAP when administered at 30 min
intervals at dosages that permit determination of myocardial area at risk and
infarct size in our canine preparation.
